CMS offers financial incentives for quality program

Article

S

The Centers for Medicare & Medicaid Services is trying a new way to recruit physicians to participate in a voluntary quality reporting program: a bonus payment of 1.5% of the total allowed charges for covered Medicare physician fee-scheduled services.

Physicians eligible to participate in the 2007 Physician Quality Reporting Initiative will choose from 74 specifications applicable to their practices to voluntarily report between July 1 and Dec. 31. To get the bonus (which is subject to a cap), physicians must report on three measures for 80% of the patients to whom these measures apply. So for instance, if a doctor reports on three of the diabetes measures-blood pres-sure, hemoglobin A1c, and low-density lipoprotein controls-for 80% of his diabetic patients during the 6-month period, he or she will receive the bonus for all of the patients treated, regardless of whether they are diabetic or not.

Time will tell if the financial incentive tempts doctors into participating, or if it could even lead to a more comprehensive reporting initiative. Rick Kellerman, president of the American Academy of Family Physicians is optimistic. He told Modern Healthcare (4/9/2007), "This is where the train is going in terms of how physicians are going to be getting paid in the future."

Recent Videos
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Empowering women to take charge of their health | Image Credit: © piecesofi.com - © piecesofi.com - stock.adobe.com.
Supporting women through menopause with knowledge and care | Image Credit: © SHOTPRIME STUDIO - © SHOTPRIME STUDIO - stock.adobe.com.
How fezolinetant revolutionizes non-hormonal menopause therapy | Image Credit: imsociety.org
Gulf War exposures linked to early menopause in women veterans | Image Credit: linkedin.com.
Vanessa Muñiz discusses benefits of clinical hypnosis against hot flashes | Image Credit: mindbodymedicine.artsandsciences.baylor.edu
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
© 2024 MJH Life Sciences

All rights reserved.